Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. PT Indofarma Tbk's Average Total Inventories for the quarter that ended in Sep. 2023 was Rp250,060 Mil. PT Indofarma Tbk's Revenue for the
three
months ended in Sep. 2023 was Rp81,737 Mil.
PT Indofarma Tbk's Inventory-to-Revenue for the quarter that ended in Sep. 2023 was 3.06.
PT Indofarma Tbk's Inventory-to-Revenue for the quarter that ended in Sep. 2023
increased
from Jun. 2023 (1.35) to Jun. 2023 (3.06)
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
PT Indofarma Tbk's Days Inventory for the
three
months ended in Sep. 2023 was 268.12.
Inventory Turnover measures how fast the company turns over its inventory within a year.
PT Indofarma Tbk's Inventory Turnover for the quarter that ended in Sep. 2023 was 0.34.
PT Indofarma Tbk Inventory-to-Revenue Historical Data
The historical data trend for PT Indofarma Tbk's Inventory-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of PT Indofarma Tbk's Inventory-to-Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, PT Indofarma Tbk's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Indofarma Tbk's Inventory-to-Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PT Indofarma Tbk's Inventory-to-Revenue distribution charts can be found below:
* The bar in red indicates where PT Indofarma Tbk's Inventory-to-Revenue falls into.
PT Indofarma Tbk Inventory-to-Revenue Calculation
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
PT Indofarma Tbk's Inventory-to-Revenue for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
More Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
PT Indofarma Tbk's Days Inventory for the
three
months ended in Sep. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Indofarma Tbk Inventory-to-Revenue Related Terms
Thank you for viewing the detailed overview of PT Indofarma Tbk's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
PT Indofarma Tbk is a specialty and generic drug manufacturing company. The company has four business segments - Medicine, Medical Devices and others, Pharmaceutical Engineering, and Aliansi Strategis Segment. The Medicine business segment includes drug production, marketing and distribution and sales. The Medical Device Segment includes medical devices and other products. The Pharmaceutical Engineering Segment includes the sale and maintenance of packaging machines for the pharmaceutical industry to external parties.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ISX:INAF has been successfully added to your 